Showing results (1001-1010 of 1,168) with videos related to

Sort By:
Pageof 117
EMBO Molecular Medicine|January 24, 2013
A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemiaJiewen Zhu, Longen Zhou, Guikai Wu, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 2, 2017
PR Interval Prolongation and Cryptogenic Stroke: A Multicenter Retrospective StudyMayra Montalvo, Prasanna Tadi, Alexander Merkler, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trialEd Clarke, Adedapo O Bashorun, Michael Okoye, et al.
American Journal of Surgery|February 9, 2020
Incoming residents' knot-tying and suturing skills: Are medical school boot camps sufficient?Robert McMillan, Philip N Redlich, Robert Treat, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2019
Thirteen-Valent Pneumococcal Conjugate Vaccine in Children With Acute Lymphoblastic Leukemia: Protective Immunity Can Be Achieved on Completion of TreatmentJessica Bate, Ray Borrow, Julia Chisholm, et al.
Vaccine|April 30, 2019
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultationsJohan Vekemans, Jonathan Crofts, Carol J Baker, et al.
Vaccine|April 12, 2023
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (Synflorix<sup>TM</sup> and Prevenar13<sup>TM)</sup>) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian childrenAnand Kawade, Girish Dayma, Aditi Apte, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2013
Human rhinovirus species C infection in young children with acute wheeze is associated with increased acute respiratory hospital admissionsDesmond W Cox, Joelene Bizzintino, Giovanni Ferrari, et al.
Vaccine|October 15, 2013
Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster doseEls van Westen, Gerwin D Rodenburg, Elske J M van Gils, et al.
The Lancet. Infectious Diseases|January 11, 2021
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trialKimberly Davis, Marta Valente Pinto, Nick J Andrews, et al.
Pageof 117